A Sub‐Microsecond Switch Enabling SWIFT 23 Na Imaging at 10. 5 T
Magnetic Resonance in Medicine · 2026-10 · 96 (4) · 1991-2003
DOI: 10.1002/mrm.70461 ↗At a glance
Journal article in Magnetic Resonance in Medicine, published online on 2026-06-08. Written by Russell L Lagore and 10 co-authors. Institution: Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Magnetic Resonance Imaging, Signal Processing, Computer-Assisted, Sodium. 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIBIB NIH HHS, NCRR NIH HHS, NIH HHS.
Abstract (original language)
Purpose
To enable sodium SWIFT imaging, which is a zero‐echo time imaging technique, at ultra‐high magnetic fields through the development of custom electronics hardware, and to showcase this capability with in vivo imaging results.
Methods
The custom hardware developed consists of a high‐speed optical trigger with 10 ns resolution, an in‐bore PIN diode driver capable of sourcing high current, and RF switches (both an in‐line switchable attenuator and transmit/receive switch) optimized to achieve sub‐microsecond switching speeds while also producing isolation between the transmitter and receiver.
Results
Practical switching speeds of 0.6 μs (receive to transmit) and 1.7 μs (transmit to receive) are achieved on the RF switches, limited by transient‐induced spurious emissions from the low noise amplifier. Transmit to receive isolation of 115 dB is achieved over a 1 MHz bandwidth, with 120 dB of isolation at the Larmor frequency. This was crucial to suppress unblanked RFPA noise. SWIFT images of the human wrist with 1.5 mm isotropic resolution were acquired in less than 5 min to demonstrate the utility of sodium SWIFT imaging at ultra‐high field. SWIFT imaging signal‐to‐noise ratio in a reference phantom with heterogeneous sodium concentrations was comparable to ultra‐short echo time imaging, which provided assurance that hardware had achieved the necessary specifications.
Conclusions
The feasibility of sodium SWIFT imaging at ultra‐high field was established, and a musculoskeletal imaging application was demonstrated. The success of this work enables further development of SWIFT at high and ultra‐high fields for imaging of sodium, proton, and other nuclei.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Magnetic Resonance Research (CMRR), University of Minnesota, Minneapolis, Minnesota, USA.
- German Cancer Research Center (DKFZ), Heidelberg, Germany.
- ETH Zürich, Institute for Biomedical Engineering, ETH Zurich and University of Zurich, Zurich, Switzerland.
- Department of Biomedical Engineering, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID profiles: Russell L Lagore, Edward J Auerbach, Naoharu Kobayashi, Steen Moeller, Elnaz Mahmoudi Mahmoudalilou, Štefan Zbýň, Jutta Ellermann, Gregor Adriany, Gregory J Metzger
Funding
- NIBIB NIH HHS
- NCRR NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Lagore, R. L., Schmidt, S., Auerbach, E. J., Kobayashi, N., Schildknecht, C., Moeller, S., Mahmoudalilou, E. M., Zbýň, Š., Ellermann, J., Adriany, G., & Metzger, G. J. (2026). A Sub‐Microsecond Switch Enabling SWIFT 23 Na Imaging at 10. 5 T. Magnetic Resonance in Medicine, 96(4), 1991-2003. https://doi.org/10.1002/mrm.70461
Vancouver
Lagore RL, Schmidt S, Auerbach EJ, Kobayashi N, Schildknecht C, Moeller S, et al. A Sub‐Microsecond Switch Enabling SWIFT 23 Na Imaging at 10. 5 T. Magnetic Resonance in Medicine. 2026;96(4):1991-2003. doi:10.1002/mrm.70461
BibTeX
@article{Lagore2026,
author = {Lagore, Russell L and Schmidt, Simon and Auerbach, Edward J and Kobayashi, Naoharu and Schildknecht, Christoph and Moeller, Steen and Mahmoudalilou, Elnaz Mahmoudi and Zbýň, Štefan and Ellermann, Jutta and Adriany, Gregor and Metzger, Gregory J},
title = {A Sub‐Microsecond Switch Enabling SWIFT 23 Na Imaging at 10. 5 T},
journal = {Magnetic Resonance in Medicine},
year = {2026},
volume = {96},
number = {4},
pages = {1991--2003},
doi = {10.1002/mrm.70461}
}
EUVIMED